Georgia
Upcoming SlideShare
Loading in...5
×
 

Georgia

on

  • 306 views

 

Statistics

Views

Total Views
306
Views on SlideShare
306
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Georgia Georgia Presentation Transcript

  • Overview of HIV/AIDS in Georgia Ketevan Mshvidobadze, MD, PhD
  • Women 524 Men 1526 Distribution of HIV/AIDS Patients by Sex and Age Groups Age distribution 2050 Infectious Diseases, AIDS & Clinical Immunology Research Center AIDS - 1044 Deaths - 440
  •  
  • HIV Cases Registered in Georgia Annually Number of cases Infectious Diseases, AIDS & Clinical Immunology Research Center
  • Distribution of HIV Cases by Routes of Transmission Infectious Diseases, AIDS & Clinical Immunology Research Center
  • Universal Access to HIV Treatment, Care and Support and Prevention Georgia Is the First Among FSU Countries that from 2004 Ensured Universal (100%) Access to ARV Treatment. Infectious Diseases, AIDS & Clinical Immunology Research Center
  • RUS * ARM* KAZ* KGZ* UZB* TKM TJK* AZE* BEL* UKR * no HAART individuals on HAART (<1%) * in the process of scaling up ART very poor access ( 1-25%) poor access (25-50%) disputed coverage estimates or insufficient data available moderate access (50-75%) good access (over 75%) ALB* FYM* GEO Access to HAART, 2008
  • National AIDS Center Three Regional AIDS Treatment Centers Tbilisi Batumi Zugdidi Kutaisi Infectious Diseases, AIDS & Clinical Immunology Research Center Decentralisation of HIV Treatment and Care Process in Georgia
  • ARV Treatment 547 Patients are currently receiving ART 521 adults 26 children Infectious Diseases, AIDS & Clinical Immunology Research Center
  • Salvage Regimens – WHO (Regimens for highly treatment experienced patients)
    • Currently available:
      • Enfurvitide (Fusion inhibitor)
      • Darunavir (PI)
    • Starting 2010 through extended Global Fund project:
      • Raltegravir (Integrase inhibitor)
      • Etravirine (NNRTI)
      • Tipranavir (PI)
      • Maraviroc (Entry inhibitor)
    Infectious Diseases, AIDS & Clinical Immunology Research Center
  • Thank you